Biosimilars and Follow-on Biologic Market Report

China Biosimilars and Follow-on Biologic Industry Market Research Report 2023-2029

  • POSTDATE：Sep 05, 2023
  • PAGES：188
  • REPORT CODE：GMM1778390
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Biosimilars and Follow-on Biologic industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Johnson & Johnson

    • Abbott

    • 3SBio

    • Biogen Idec

    • GlaxoSmithKline (GSK)

    • Genentech

    • Alexion Pharmaceuticals,

    • Sandoz

    • Bristol-Myers Squibb

    • Zenotech

    • Mitsubishi Tanabe Pharma Corporation

    • CCL Pharmaceuticals

    • Dr Reddy’s Laboratories

    By Type:

    • Insulin

    • Interferon

    • Erythropoietin

    • Monoclonal Antibodies

    • Human Growth Hormone

    • Others

    • Granulocyte-Colony Stimulating Factor

    By Application:

    • Chronic & Autoimmune Diseases

    • Oncology Diseases

    • Growth Hormone Deficiencies

    • Others

    • Blood Disorders

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Biosimilars and Follow-on Biologic Market Overview 2018-2029

    • 1.1 China Biosimilars and Follow-on Biologic Industry Development Overview

    • 1.2 China Biosimilars and Follow-on Biologic Industry Development History

    • 1.3 China Biosimilars and Follow-on Biologic Industry Market Size (2018-2029)

    • 1.4 China Biosimilars and Follow-on Biologic Market Analysis by Type from Production Side

      • 1.4.1 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

      • 1.4.2 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Interferon (2018-2029)

      • 1.4.3 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

      • 1.4.4 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.5 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Human Growth Hormone (2018-2029)

      • 1.4.6 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.7 China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2029)

    • 1.5 China Biosimilars and Follow-on Biologic Market Analysis by Application from Consumption End

      • 1.5.1 China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Chronic & Autoimmune Diseases (2018-2029)

      • 1.5.2 China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Oncology Diseases (2018-2029)

      • 1.5.3 China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiencies (2018-2029)

      • 1.5.4 China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

    • 1.6 China Biosimilars and Follow-on Biologic Market Analysis by Region

      • 1.6.1 North China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    Chapter 2 China Biosimilars and Follow-on Biologic Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Biosimilars and Follow-on Biologic Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Biosimilars and Follow-on Biologic Market Status and Competition Analysis in 2023

      • 2.2.3 China Biosimilars and Follow-on Biologic Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Biosimilars and Follow-on Biologic Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Biosimilars and Follow-on Biologic Industry Development

    Chapter 3 Biosimilars and Follow-on BiologicIndustry Chain Analysis

    • 3.1 Biosimilars and Follow-on Biologic Industry Chain

    • 3.2 Biosimilars and Follow-on Biologic Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Biosimilars and Follow-on Biologic Market

    • 3.3 Biosimilars and Follow-on Biologic Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Biosimilars and Follow-on Biologic Market

    Chapter 4 China Biosimilars and Follow-on Biologic Market, by Type

    • 4.1 China Biosimilars and Follow-on Biologic Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Biosimilars and Follow-on Biologic Total Production Volume and Growth Rate from Production Side

    • 4.5 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate, by Type

      • 4.5.1 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Insulin

      • 4.5.2 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Interferon

      • 4.5.3 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Erythropoietin

      • 4.5.4 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.5 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Human Growth Hormone

      • 4.5.6 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Others

      • 4.5.7 China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor

    Chapter 5 China Biosimilars and Follow-on Biologic Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Biosimilars and Follow-on Biologic Total Market Size and Growth Rate from Consumption End

    • 5.5 China Biosimilars and Follow-on Biologic Market Size and Growth Rate, by Application

      • 5.5.1 China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Chronic & Autoimmune Diseases

      • 5.5.2 China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Oncology Diseases

      • 5.5.3 China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Growth Hormone Deficiencies

      • 5.5.4 China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Others

      • 5.5.5 China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Blood Disorders

    Chapter 6 China Biosimilars and Follow-on Biologic Market, by Region

    • 6.1 China Biosimilars and Follow-on Biologic Production Volume and Production Value, by Region

    • 6.2 China Biosimilars and Follow-on Biologic Sales Volume and Sales Value, by Region

    Chapter 7 North China Biosimilars and Follow-on Biologic Market Analysis

    • 7.1 North China Biosimilars and Follow-on Biologic Market, by Type

    • 7.2 North China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 8 Central China Biosimilars and Follow-on Biologic Market Analysis

    • 8.1 Central China Biosimilars and Follow-on Biologic Market, by Type

    • 8.2 Central China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 9 South China Biosimilars and Follow-on Biologic Market Analysis

    • 9.1 South China Biosimilars and Follow-on Biologic Market, by Type

    • 9.2 South China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 10 East China Biosimilars and Follow-on Biologic Market Analysis

    • 10.1 East China Biosimilars and Follow-on Biologic Market, by Type

    • 10.2 East China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 11 Northeast China Biosimilars and Follow-on Biologic Market Analysis

    • 11.1 Northeast China Biosimilars and Follow-on Biologic Market, by Type

    • 11.2 Northeast China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 12 Southwest China Biosimilars and Follow-on Biologic Market Analysis

    • 12.1 Southwest China Biosimilars and Follow-on Biologic Market, by Type

    • 12.2 Southwest China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 13 Northwest China Biosimilars and Follow-on Biologic Market Analysis

    • 13.1 Northwest China Biosimilars and Follow-on Biologic Market, by Type

    • 13.2 Northwest China Biosimilars and Follow-on Biologic Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Johnson & Johnson

        • 14.1.1 Johnson & Johnson Company Profile

        • 14.1.2 Johnson & Johnson Biosimilars and Follow-on Biologic Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Abbott

        • 14.2.1 Abbott Company Profile

        • 14.2.2 Abbott Biosimilars and Follow-on Biologic Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 3SBio

        • 14.3.1 3SBio Company Profile

        • 14.3.2 3SBio Biosimilars and Follow-on Biologic Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Biogen Idec

        • 14.4.1 Biogen Idec Company Profile

        • 14.4.2 Biogen Idec Biosimilars and Follow-on Biologic Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 GlaxoSmithKline (GSK)

        • 14.5.1 GlaxoSmithKline (GSK) Company Profile

        • 14.5.2 GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Genentech

        • 14.6.1 Genentech Company Profile

        • 14.6.2 Genentech Biosimilars and Follow-on Biologic Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Alexion Pharmaceuticals,

        • 14.7.1 Alexion Pharmaceuticals, Company Profile

        • 14.7.2 Alexion Pharmaceuticals, Biosimilars and Follow-on Biologic Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sandoz

        • 14.8.1 Sandoz Company Profile

        • 14.8.2 Sandoz Biosimilars and Follow-on Biologic Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Bristol-Myers Squibb

        • 14.9.1 Bristol-Myers Squibb Company Profile

        • 14.9.2 Bristol-Myers Squibb Biosimilars and Follow-on Biologic Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Zenotech

        • 14.10.1 Zenotech Company Profile

        • 14.10.2 Zenotech Biosimilars and Follow-on Biologic Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Mitsubishi Tanabe Pharma Corporation

        • 14.11.1 Mitsubishi Tanabe Pharma Corporation Company Profile

        • 14.11.2 Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 CCL Pharmaceuticals

        • 14.12.1 CCL Pharmaceuticals Company Profile

        • 14.12.2 CCL Pharmaceuticals Biosimilars and Follow-on Biologic Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Dr Reddy’s Laboratories

        • 14.13.1 Dr Reddy’s Laboratories Company Profile

        • 14.13.2 Dr Reddy’s Laboratories Biosimilars and Follow-on Biologic Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Biosimilars and Follow-on Biologic Industry Research Conclusions

    • 15.2 Biosimilars and Follow-on Biologic Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Biosimilars and Follow-on Biologic Industry Market Size (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Interferon (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Human Growth Hormone (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Chronic & Autoimmune Diseases (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Oncology Diseases (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Growth Hormone Deficiencies (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)

    • Figure North China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure Central China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure South China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure East China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Biosimilars and Follow-on Biologic Market Size and Growth Rate from 2018-2029

    • Figure Biosimilars and Follow-on Biologic Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Biosimilars and Follow-on Biologic Market Share by Type in 2018

    • Figure China Biosimilars and Follow-on Biologic Market Share by Type in 2023

    • Figure China Biosimilars and Follow-on Biologic Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Insulin (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Interferon (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Erythropoietin (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Human Growth Hormone (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Market Share by Application in 2018

    • Figure China Biosimilars and Follow-on Biologic Market Share by Application in 2023

    • Figure China Biosimilars and Follow-on Biologic Total Market Size and Growth Rate from Consumption End

    • Figure China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Chronic & Autoimmune Diseases (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Oncology Diseases (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Growth Hormone Deficiencies (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Others (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Market Size and Growth Rate of Blood Disorders (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Production Volume by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Production Volume Share by Region (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Volume Share by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Production Value by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Production Value Share by Region (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Production Value Share by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Sales Volume by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Sales Volume Share by Region (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Sales Volume Share by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Sales Value by Region (2018-2023)

    • Table China Biosimilars and Follow-on Biologic Sales Value Share by Region (2018-2023)

    • Figure China Biosimilars and Follow-on Biologic Sales Value Share by Region (2018-2023)

    • Table North China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table North China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure North China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table North China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table North China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure North China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table Central China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table Central China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure Central China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table Central China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table Central China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure Central China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table South China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table South China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure South China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table South China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table South China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure South China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table East China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table East China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure East China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table East China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table East China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure East China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table Northeast China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table Northeast China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure Northeast China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table Northeast China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table Northeast China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table Southwest China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table Southwest China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure Southwest China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table Southwest China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table Southwest China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table Northwest China Biosimilars and Follow-on Biologic Production Volume by Type (2018-2023)

    • Table Northwest China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Figure Northwest China Biosimilars and Follow-on Biologic Production Volume Share by Type (2018-2023)

    • Table Northwest China Biosimilars and Follow-on Biologic Sales Volume by Application (2018-2023)

    • Table Northwest China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Biosimilars and Follow-on Biologic Sales Volume Share by Application (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table 3SBio Company Profile

    • Table 3SBio Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline (GSK) Company Profile

    • Table GlaxoSmithKline (GSK) Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Alexion Pharmaceuticals, Company Profile

    • Table Alexion Pharmaceuticals, Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Zenotech Company Profile

    • Table Zenotech Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Mitsubishi Tanabe Pharma Corporation Company Profile

    • Table Mitsubishi Tanabe Pharma Corporation Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table CCL Pharmaceuticals Company Profile

    • Table CCL Pharmaceuticals Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy’s Laboratories Company Profile

    • Table Dr Reddy’s Laboratories Biosimilars and Follow-on Biologic Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US